Exubera professional ads
Executive Summary
Aventis and Pfizer name Lally McFarland & Pantello as agency of record for inhaled insulin product Exubera, currently in Phase III. LM&P will be responsible for professional ads worldwide. The agency has worked previously with Aventis on hormone replacement therapy CombiPatch (estradiol/norethindrone), and is currently working with Pfizer/Pharmacia on the second-generation COX-2 inhibitor valdecoxib